Skip to main content
. Author manuscript; available in PMC: 2014 Oct 3.
Published in final edited form as: Semin Hematol. 2013 Oct 3;50(4):271–283. doi: 10.1053/j.seminhematol.2013.09.006

Table 3.

Criteria for Response/Failure and Change of Therapy

Time (mo) Imatinib Second generation TKI
3–6 MCyR; BCR-ABL transcript levels≤10% (IS) CCyR; BCR-ABL transcript levels≤1% (IS)
12 CCyR; BCR-ABL transcript levels≤1% (IS) CCyR; BCR-ABL transcript levels≤1% (IS)
Later CCyR; BCR-ABL transcript levels≤1% (IS) CCyR; BCR-ABL transcript levels≤1% (IS)

Note. MCyR roughly = BCR-ABL≤10% (IS); CCyR roughly = BCR-ABL≤1% (IS).

Abbreviations: MCyR, major cytogenetic response (Ph≤35%); CCyR, complete cytogenetic response (Ph=0%); IS, International Scale.